Cebrotonin Contraindications

This product must not be applied in case of known hypersensitivity to piracetam, other pyrrolidone derivates or to one of the other ingredients; in case of cerebral haemorrhage (e.g. stroke); in case of severe renal insufficiency (renal insufficiency at terminal stage); in case of suffering from the genetic disease Huntington's chorea. In case of psychomotor agitation, also if it occurred formerly, the physician has to be consulted first.
Use in Pregnancy & Lactation: There is not enough experience concerning the application of piracetam during pregnancy. If a patient becomes pregnant during the treatment with this product, the physician has to be informed at once, in order for him to decide whether to continue or to stop therapy. Piracetam passes over to the mother's milk. This product should therefore not be applied during lactation period or alternatively breast-feeding should be interrupted during CEBROTONIN treatment. It is up to the physician to decide whether breastfeeding or CEBROTONIN treatment should be interrupted, after having weighed out the risks and benefits for the mother and the child.